Human neural stem cell transplants improve motor function in a rat model of Huntington's disease

Journal of Comparative Neurology

Volumn 475, Issue 2, 2004, Pages 211-219

  McBride, Jodi L ^a   Behrstock, Soshana P ^b   Chen, Er Yun ^a   Jakel, Rebekah J ^b   Siegel, Irwin ^a   Svendsen, Clive N ^b   Kordower, Jeffrey H ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Differentiation; Human neurospheres; Migration; Proliferation; Quinolinic acid; Xenograft

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BASAL GANGLION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; FETUS; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MALE; MOTOR PERFORMANCE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; STEREOLOGY; XENOGRAFT;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CEREBRAL CORTEX; CILIARY NEUROTROPHIC FACTOR; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GRAFT SURVIVAL; HUMANS; HUNTINGTON DISEASE; MALE; MOVEMENT; NERVE REGENERATION; NEURONS; QUINOLINIC ACID; RATS; RATS, INBRED LEW; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 3042721905     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20176     Document Type: Article

References (21)

1. Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE. 2000. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 60:409-470.
2. Caldwell MA, He X, Wilkie N, Pollack S, Marshall G, Wafford KA, Svendsen CN. 2001. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotech 19:475-479.
3. Craufurd D, Snowden J. 2002. Neuropsychological and neuropsychiatric aspects of Huntington's disease. In: Bates G, Harper P, Jones L, editors. Huntington's disease, 3rd ed. Oxford: Oxford University Press. p 62-94.
4. Dunnett SB, Isacson O, Sirinathsinghji DJS, Clark DJ, Björklund A. 1998. Striatal grafts in rats with unilateral neostriatal lesions-III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24:813-820.
5. Dunnett SB, Nathwani F, Björklund A. 2000. The integration and function of striatal grafts. Prog Brain Res 127:345-380.
6. Englund U, Bjorklund A, Wictorin K. 2002. Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res Dev Brain Res 134:123-141.
7. Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O. 2000. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci USA 97:13877-13882.
8. Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Bjorklund A. 1999. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 19:5590-6005.
9. Gutekunst C-A, Norflus F, Hersh SM. 2002. The neuropathology of Huntington's disease. In: Bates G, Harper P, Jones L, editors. Huntington's disease, 3rd ed. Oxford: Oxford University Press. p 251-273.
10. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
11. Hurelbrink CB, Armstrong RJ, Dunnett SB, Rosser AE, Barker RA. 2002. Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. Eur J Neurosci. 15:1255-1266.
12. Kremer B. 2002. Clinical neurology of Huntington's disease. In: Bates G, Harper P, Jones L, editors. Huntington's disease, 3rd ed. Oxford: Oxford University Press. p 28-61.
13. Lu P, Jones LL, Snyder EY, Tuszynski MH. 2003. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115-129.
14. Ostenfeld T, Svendsen CN. 2003. Recent advances in stem cell neurobiology. Adv Tech Stand Neurosurg 28:3-89.
15. Ostenfeld T, Joly E, Tai YT, Peters A, Caldwell M, Jauniaux E, Svendsen CN. 2002. Regional specification of rodent and human neurospheres. Brain Res Dev Brain Res 134:43-55.
16. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. 2002. Neural stem cells display an inherant mechanism for rescuing dysfunctional neurons. Nature Biotechnol 20:1103-1110.
17. Palfi S, Conde F, Riche D, Brouillet E, Dautry C, Mittoux V, Chibois A, Peschanski M, Hantraye P. 1998. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med 4:963-966.
18. Reynolds BA, Weiss S. 1996. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1-13.
19. Saji M, Reis DJ. 1987. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science 235:66-69.
20. Svendsen CN, Caldwell MA. 2000. Neural stem cells in the developing central nervous system: implications for cell therapy through transplantation. Prog Brain Res 127:13-34.
21. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA. 1998. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 85:141-152.